• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYP

CYNATA THERAPEUTICS LIMITED - Discussion

2.63% ! 19.5¢
Market Cap $46.30M  !
Healthcare Biotechnology
Add to My Watchlist

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and... Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.More

Cynata Therapeutics Limited

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Doug Diamond 127 27K 6 21/05/25
21/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread pfeifer1982 127 27K 7 21/05/25
21/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 7
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread bedger 127 27K 5 21/05/25
21/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread truss20 127 27K 4 21/05/25
21/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread pfeifer1982 127 27K 7 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 7
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread atomikrej 127 27K 2 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread gavint66 127 27K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Rossi70 127 27K 3 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 23 6.3K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread Rossi70 23 6.3K 2 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 23 6.3K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread Rossi70 23 6.3K 5 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Artephius 127 27K 4 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread gavint66 127 27K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 23 6.3K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 23 6.3K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread bedger 23 6.3K 3 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread truss20 127 27K 8 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread truss20 23 6.3K 6 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread gavint66 127 27K 2 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 2
TRENDING NEWS

Two '4D' stocks to watch, but only one winner

NEWS
11 Sep 2025
Listen Now right-arrow Created with Sketch.
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 23 6.3K 0 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread atomikrej 127 27K 4 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread bedger 23 6.3K 9 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 9
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread truss20 23 6.3K 5 20/05/25
20/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread Artephius 23 6.3K 4 19/05/25
19/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Paving the way for next-gen treatments Thread gavint66 23 6.3K 1 19/05/25
19/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 1
ASX - By Stock CYP Paving the way for next-gen treatments Thread Artephius 23 6.3K 8 19/05/25
19/05/25 ASX - By Stock Thread Comments Created with Sketch. 23 Views Created with Sketch. 6.3K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Ann: Promising Preclinical Heart Disease Data Thread gavint66 10 5.2K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 10 Views Created with Sketch. 5.2K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Promising Preclinical Heart Disease Data Thread Rossi70 10 5.2K 3 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 10 Views Created with Sketch. 5.2K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Pronewbie 22 7.9K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 22 Views Created with Sketch. 7.9K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Cynata Participating in Euroz Hartleys Investor Conference Thread Pronewbie 9 3.1K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.1K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Cynata Participating in Euroz Hartleys Investor Conference Thread Pronewbie 9 3.1K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 9 Views Created with Sketch. 3.1K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Ann: Investor Webinar Thread Pronewbie 11 3.2K 2 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.2K Likes Created with Sketch. 2
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Pronewbie 392 117K 3 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Ann: Promising Preclinical Heart Disease Data Thread Pronewbie 10 5.2K 2 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 10 Views Created with Sketch. 5.2K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.3K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.3K 2 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.3K 1 17/05/25
17/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.3K 2 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.3K 2 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 2
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.3K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.3K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.3K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 392 117K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 6
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.3K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread reginaldp 392 117K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 392 117K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.3K 3 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread reginaldp 392 117K 10 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 10
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread bedger 127 27K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Bazsa 26 6.3K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.3K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.3K 3 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Aremac 26 6.3K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Pronewbie 26 6.3K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.3K 3 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 3
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Artephius 26 6.3K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.3K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Pronewbie 127 27K 0 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread Doug Diamond 127 27K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 5
ASX - By Stock CYP Re: Ann: CYP-001s FDA Approval Pathway Not Impeded Thread truss20 127 27K 5 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 5
ASX - By Stock CYP Ann: CYP-001s FDA Approval Pathway Not Impeded Thread ASX News 127 27K 18 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 127 Views Created with Sketch. 27K Likes Created with Sketch. 18
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread bedger 392 117K 8 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 8
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread bedger 392 117K 7 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 7
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.3K 6 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Bazsa 26 6.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Doug Diamond 392 117K 8 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 8
ASX - By Stock CYP Re: Ann: Investor Webinar Thread tuts 11 3.2K 1 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 11 Views Created with Sketch. 3.2K Likes Created with Sketch. 1
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread Valueformoney 26 6.3K 4 16/05/25
16/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread coolkiat 392 117K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.3K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Rossi70 392 117K 8 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 8
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread coolkiat 392 117K 6 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 6
ASX - By Stock CYP Re: Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread gavint66 26 6.3K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Why Orphan Drug Designation for mesoblast is IRRELEVANT to Cynata Thread truss20 26 6.3K 8 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 26 Views Created with Sketch. 6.3K Likes Created with Sketch. 8
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Aremac 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread coolkiat 392 117K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Aremac 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 392 117K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 3
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 1 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 1
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 392 117K 2 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 2
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread truss20 392 117K 6 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 6
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread gavint66 392 117K 0 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 0
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread jzam 392 117K 4 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 4
ASX - By Stock CYP Re: CYP Price Target post MSB FDA approval. Thread Stockcount 392 117K 3 15/05/25
15/05/25 ASX - By Stock Thread Comments Created with Sketch. 392 Views Created with Sketch. 117K Likes Created with Sketch. 3
refresh Created with Sketch. REFRESH

Featured News

NEWS Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner
right-arrow Created with Sketch.
MEM Memphasys secures transformational A$325K initial order with exclusive Middle East partnership
right-arrow Created with Sketch.
NEWS New targets and high-grade intercepts drive Bullabulling drill expansion
right-arrow Created with Sketch.
NEWS How to handle a financial crisis and turn setbacks into setups
right-arrow Created with Sketch.
BML Boab Metals secures path to full ownership of Sorby Hills Project
right-arrow Created with Sketch.
LM1 High-grade targets in focus as drilling begins at Evanston
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
19.5¢ 		Change
0.005(2.63%) 		Mkt cap ! $46.30M
Open High Low Value Volume
19.0¢ 19.5¢ 18.0¢ $53.29K 289.3K

Buyers (Bids)

No. Vol. Price($)
1 83333 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 4869 2
View Market Depth
Last trade - 15.02pm 11/09/2025 (20 minute delay) ?
CYP (ASX) Chart

Top Stories

Afterpay owner Block shares dip after competitor Klarna lists 30% higher out the gate

Afterpay owner Block has seen its shares head towards a -3% drop as the market digests news of Klarna's successful U.S. IPO overnight.
EV Resources snaps up Nevada antimony project; will raise $5.5M for it, Los Lirios EV Resources has come out of its halt with a bang, unveiling the acquisition of the Dollar Antimony Project in Nye County alongside a raise.
Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
EVR opens strong with funding, acquisition, and sales agreement announcements EVR has caught attention on the HotCopper forums and across the wider Australian markets today with a flurry of announcements.
Market Close: Aussie traders divorce from US as retreat continues. At least there's 4DX Good Afternoon and welcome to HotCopper’s Market Close for Thursday 11th of September, I’m Jon Davidson. We’ve truly diverted from Wall Street at the start of September with the local bourse retreating once again this week, showing an Australian inv...

Featured News

NEWS How to handle a financial crisis and turn setbacks into setups
right-arrow Created with Sketch.
LM1 High-grade targets in focus as drilling begins at Evanston
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner
right-arrow Created with Sketch.
NEWS The 4 sectors poised to benefit from Australia's immigration wave
right-arrow Created with Sketch.
AII Why Almonty Industries is THE tungsten mining stock to watch
right-arrow Created with Sketch.
NEWS Outstanding thick high-grade gold revealed in first Greenewood assays
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.